PISCATAWAY, N.J., April 26, 2025 /PRNewswire/ -- Bestzyme is pleased to announce a flagship product Mellia™ Brazzein, has officially received the "No Questions" letter from the U.S. Food and Drug Administration (FDA) regarding its GRAS (Generally Recognized as Safe) status. The GRAS...
Hence then, the article about bestzyme s mellia brazzein receives fda no questions letter bringing creative sugar reduction solution to global market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market )
Also on site :